| Literature DB >> 30504221 |
Urszula Godlewska1, Bernadetta Bilska2, Aneta Zegar1, Piotr Brzoza1, Arkadiusz Borek3, Krzysztof Murzyn4, Oliwia Bochenska5, Agnieszka Morytko1, Patryk Kuleta3, Andrzej Kozik5, Elzbieta Pyza2, Artur Osyczka3, Brian A Zabel6, Joanna Cichy7.
Abstract
Chemerin is a leukocyte attractant, adipokine, and antimicrobial protein abundantly produced in the skin epidermis. Despite the fact that most of the bactericidal activity present in human skin exudates is chemerin-dependent, just how chemerin shapes skin defenses remains obscure. Here we demonstrate that p4, a potent antimicrobial human chemerin peptide derivative, displays killing activity against pathogenic methicillin-resistant Staphylococcus aureus strains and suppresses microbial growth in a topical skin infection model. Mechanistically, we show that p4 homodimerization is required for maximal bactericidal activity and that an oxidative environment, such as at the skin surface, facilitates p4 disulfide bridge formation, required for the dimerization. p4 led to rapid damage of the bacterial internal membrane and inhibited the interaction between the membranous cytochrome bc 1 complex and its redox partner, cytochrome c These results suggest that a chemerin p4-based defense strategy combats bacterial challenges at the skin surface.Entities:
Keywords: MRSA; Staphylococcus aureus (S. aureus); adipokine; antimicrobial peptide (AMP); bacteria; chemerin; chemotaxis; epidermis; host defense; host–pathogen interaction; skin
Mesh:
Substances:
Year: 2018 PMID: 30504221 PMCID: PMC6349111 DOI: 10.1074/jbc.RA118.005495
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157